Anti-CD70 Antibody-Drug Conjugate MDX-1203

An antibody-drug conjugate (ADC) containing a fully human monoclonal antibody, directed against the extracellular domain of the human CD70 molecule, conjugated to a prodrug of a CC-1065 (rachelmycin) analogue via a stable peptide-based linker, with potential antineoplastic activity. The anti-CD70 antibody moiety of the anti-CD70 antibody-drug conjugate MDX-1203 selectively binds to the extracellular domain of CD70 on tumor cell surfaces. Upon internalization, the prodrug moiety is released and activated and binds to double-stranded B-DNA within the minor groove, thereby alkylating the -3 position of adenine, which may result in the inhibition of cellular proliferation of tumor cells that overexpress CD70. CD70, the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis factor (TNF) family, is found on the surfaces of various types of cancer cells. The antitumor antibiotic CC-1065, a DNA minor-groove-binding alkylating agent, was originally isolated from the bacterium Streptomyces zelensis. (NCI Thesaurus)

YOU MAY ALSO LIKE

Anti-CD7 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD7, regardless of the antibody type.

Anti-CD7 Immunotoxin

A toxin linked to an anti-CD7 antibody.

Anti-CD6 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD6, regardless of the antibody type.

Anti-CD52 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).

Anti-CD5 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD5, regardless of the antibody type.

Anti-CD45 Monoclonal Antibody BC8

A murine IgG1 anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity. CD45 antigen, a receptor protein-tyrosine phosphatase essential for T cell development and…